0.57% 0.18

Tg Therapeutics Inc (TGTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TGTX? Forum Prognose Aktiensplit

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.79% 141.15	120.86	108.19	83.88	73.47
Cost Of Revenue	21.86% 18.94	15.54	15.40	9.341	8.304
Gross Profit	16.04% 122.21	105.31	92.79	74.54	65.16
Operating Expenses	9.64% 87.37	96.69	62.84	62.10	56.35
Benefits Costs and Expenses	4.47% 110.23	115.39	82.73	79.61	66.92
Costs And Expenses	5.28% 106.31	112.23	78.24	71.44	64.65
Operating Income/Loss	304.12% 34.84	8.622	29.95	12.43	8.816
Nonoperating Income/Loss	24.38% -3.923	-3.154	-4.496	-8.166	-2.265
Income/Loss From Continuing Operations Before Tax	465.47% 30.92	5.468	25.45	4.268	6.551
Income Tax Expense/Benefit	569.85% 2.733	0.408	2.122	0.388	-0.328
Income/Loss From Continuing Operations After Tax	457.06% 28.19	5.06	23.33	3.88	6.879
Net Income/Loss	457.06% 28.19	5.06	23.33	3.88	6.879
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.04% 146.74	146.68	-0.0249	145.10	144.73
Diluted Average Shares	0.13% 162.56	162.77	-0.0309	160.71	159.42
Basic Earnings Per Share	533.33% 0.19	0.03	0.16	0.03	0.05
Diluted Earnings Per Share	466.67% 0.17	0.03	0.15	0.02	0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%